Gefitinib Unknown Status Phase 2 Trials for Esophageal Cancers Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01291823Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer